Top IconTOP
β-Amyloid 1-42 (Aβ1-42) (CLIA)
< >
β-Amyloid 1-42 (Aβ1-42) (CLIA)

β-Amyloid 1-42 (Aβ1-42) (CLIA)

Size
Cat. No.
β-Amyloid 1-42 (Aβ1-42) (CLIA)
β-Amyloid 1-42 (Aβ1-42) (CLIA)
Size
Cat. No.

Product Detail

 Product Description  

The Vazyme β-Amyloid 1-42 (Aβ1-42) CLIA Assay is designed for quantitative measurement of Aβ1-42 in research samples for Alzheimer’s disease biomarker studies. It supports automated chemiluminescence immunoassay workflows on compatible analyzers.

This Aβ1-42 immunoassay uses a double-antibody sandwich format. Monoclonal anti-Aβ1-42 antibodies coated onto magnetic particles serve as capture antibodies, while acridinium ester-labeled monoclonal anti-Aβ1-42 antibodies function as detection antibodies. The relative light units (RLUs) measured are directly proportional to the Aβ1-42 concentration in the sample.

β-Amyloid 1-40 (Aβ1-40) (CLIA) Features  

  • Automated CLIA Workflow. Compatible with automated chemiluminescence immunoassay analyzers for streamlined Aβ1-42 quantification in research workflows.

  • Proprietary High-affinity Antibodies. In-house developed monoclonal anti-Aβ1-42 antibodies enable sensitive and specific detection.

  • Defined Analytical Performance. Limit of Blank (LoB) ≤0.50 pg/mL; linear range 1.00–100.00 pg/mL with correlation coefficient r ≥0.9900.

  • Precision and Trueness Specifications. Repeatability CV ≤8.00%, intermediate precision CV ≤15.00%, and trueness within −15% to +15%.

 Specification  

SpecificationPerformance
Product nameβ-Amyloid 1-42 (Aβ1-42) CLIA Assay
Catalog numberAD008
Pack size100 tests/kit
PrincipleDouble-antibody sandwich chemiluminescence immunoassay (CLIA)
Species Reactivity (Validated)human, 5xFAD mice, Non-human primate, pig, brain organoids
Sample typeEDTA plasma, CSF, brain homogenate, Cell Culture Supernatant
LoB≤0.50 pg/mL
Linear range1.00–100.00 pg/mL
Linear correlation coefficientr ≥0.9900
Repeatability (CV)≤8.00%
Intermediate precision (CV)≤15.00%
Trueness−15% to +15%
Calibrators3 levels
Quality control2 levels
Compatible analyzerElf S290R
Sample Volume50μL
Storage2–8 °C, protected from light
Shelf life12 months
Intended useResearch Use Only (RUO)

 Reasearch Application   

  • Quantitative Aβ1-42 measurement in research samples for Alzheimer’s disease biomarker research.

  • Aβ1-42 / Aβ1-40 ratio studies to support amyloid pathology characterization.

  • Multi-biomarker panels together with Aβ1-40, p-Tau 217, p-Tau 181, GFAP, and NfL.

  • Longitudinal and cohort monitoring of Aβ1-42 dynamics in research cohorts.

 Assay Principle  

The assay uses a double-antibody sandwich format. Magnetic particles coated with capture antibody bind Aβ1-42 from the sample; an acridinium ester-labeled detection antibody produces a chemiluminescent signal (RLU) proportional to the Aβ1-42 concentration.

  1. Magnetic-particle capture: capture antibodies on magnetic particles bind Aβ1-42 from the sample.

  2. Wash: unbound material is removed before detection.

  3. Acridinium-ester detection antibody: the labeled antibody completes the sandwich complex.

  4. RLU signal: the chemiluminescent signal is proportional to the Aβ1-42 concentration.

β-Amyloid 1-40 (Aβ1-40) (CLIA)Kit Contents and Compatibility   

Compatible instruments

Automatic Chemiluminescence Immunoassay Analyzer, Model Elf S290R

Kit contents

Our ready-to-use β-Amyloid 1-42 (Aβ1-42) (CLIA) kits contain all the reagents necessary to run your Aβ1-42 assays. Each kit contains enough reagents for 100 tests.

ComponentQuantity (per 100-test kit)
Magnetic Particle Suspension5.0 mL
Labeled Antibody Working Solution11.0 mL
Assay Diluent6.0 mL
Quality Control Materials1 set
Calibrators1 set
For Research Use Only. Not for use in diagnostic procedures.